153 related articles for article (PubMed ID: 33640702)
1. Pleomorphic giant cell carcinoma of prostate: Rare tumor with unique clinicopathological, immunohistochemical, and molecular features.
El-Zaatari ZM; Thomas JS; Divatia MK; Shen SS; Ayala AG; Monroig-Bosque P; Shehabeldin A; Ro JY
Ann Diagn Pathol; 2021 Jun; 52():151719. PubMed ID: 33640702
[TBL] [Abstract][Full Text] [Related]
2. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
Gordetsky J; Epstein JI
Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation.
Samaratunga H; Delahunt B; Egevad L; Adamson M; Hussey D; Malone G; Hoyle K; Nathan T; Kerle D; Ferguson P; Nacey JN
Histopathology; 2016 Mar; 68(4):533-40. PubMed ID: 26211928
[TBL] [Abstract][Full Text] [Related]
4. Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 Cases.
Alharbi AM; De Marzo AM; Hicks JL; Lotan TL; Epstein JI
Am J Surg Pathol; 2018 Oct; 42(10):1286-1296. PubMed ID: 29944471
[TBL] [Abstract][Full Text] [Related]
5. Pleomorphic giant cell carcinoma of the urinary bladder.
Lopez-Beltran A; Blanca A; Montironi R; Cheng L; Regueiro JC
Hum Pathol; 2009 Oct; 40(10):1461-6. PubMed ID: 19467692
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomes.
Bilé-Silva A; Lopez-Beltran A; Rasteiro H; Vau N; Blanca A; Gomez E; Gaspar F; Cheng L
Virchows Arch; 2023 Mar; 482(3):493-505. PubMed ID: 36600115
[TBL] [Abstract][Full Text] [Related]
7. HOXB13 a useful marker in pleomorphic giant cell adenocarcinoma of the prostate: a case report and review of the literature.
Larnaudie L; Compérat E; Conort P; Varinot J
Virchows Arch; 2017 Jul; 471(1):133-136. PubMed ID: 28484843
[TBL] [Abstract][Full Text] [Related]
8. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
Alhamar M; Tudor Vladislav I; Smith SC; Gao Y; Cheng L; Favazza LA; Alani AM; Ittmann MM; Riddle ND; Whiteley LJ; Gupta NS; Carskadon S; Gomez-Gelvez JC; Chitale DA; Palanisamy N; Hes O; Trpkov K; Williamson SR
Histopathology; 2020 Dec; 77(6):890-899. PubMed ID: 32639612
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic giant cell carcinoma of the prostate: A case report and mini‑review of the literature.
Fakhralddin SS; Ali RM; Abdullah AM; Faraj FM; Hussein DM; Mohammed SH; Abdalla BA; Kakamad FH; Rahim HM
Med Int (Lond); 2023; 3(6):60. PubMed ID: 38222251
[TBL] [Abstract][Full Text] [Related]
10. Polyomavirus (BK)-associated pleomorphic giant cell carcinoma of the urinary bladder: a case report.
Alexiev BA; Papadimitriou JC; Chai TC; Ramos E; Staats PN; Drachenberg CB
Pathol Res Pract; 2013 Apr; 209(4):255-9. PubMed ID: 23481349
[TBL] [Abstract][Full Text] [Related]
11. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid carcinoma of the prostate: a study of 42 cases.
Hansel DE; Epstein JI
Am J Surg Pathol; 2006 Oct; 30(10):1316-21. PubMed ID: 17001164
[TBL] [Abstract][Full Text] [Related]
13. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Humphrey PA; Moch H; Cubilla AL; Ulbright TM; Reuter VE
Eur Urol; 2016 Jul; 70(1):106-119. PubMed ID: 26996659
[TBL] [Abstract][Full Text] [Related]
14. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
Chan E; Garg K; Stohr BA
Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic giant cell carcinoma of the prostate.
Lopez-Beltran A; Eble JN; Bostwick DG
Arch Pathol Lab Med; 2005 May; 129(5):683-5. PubMed ID: 15859643
[TBL] [Abstract][Full Text] [Related]
16. Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma.
Huang Q; Chu PG; Lau SK; Weiss LM
Hum Pathol; 2004 Jun; 35(6):769-73. PubMed ID: 15188146
[TBL] [Abstract][Full Text] [Related]
17. HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors.
Barresi V; Ieni A; Cardia R; Licata L; Vitarelli E; Reggiani Bonetti L; Tuccari G
APMIS; 2016 Mar; 124(3):188-93. PubMed ID: 26590121
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases.
Parwani AV; Herawi M; Epstein JI
Am J Surg Pathol; 2006 Oct; 30(10):1254-9. PubMed ID: 17001156
[TBL] [Abstract][Full Text] [Related]
19. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
Compérat E
Ann Pathol; 2017 Jun; 37(3):232-234. PubMed ID: 28554779
[No Abstract] [Full Text] [Related]
20. Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy.
Arista-Nasr J; Martinez-Benitez B; Bornstein-Quevedo L; Aguilar-Ayala E; Aleman-Sanchez CN; Ortiz-Bautista R
Int Braz J Urol; 2016; 42(2):247-52. PubMed ID: 27256178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
